Cel Sci Corporation (CVM)

[GD]

Abstracts and late-breaking abstracts accepted for presentation at the ESMO Virtual Congress 2020 as Mini Oral (suffix ‘MO’) will be published online via the ESMO website at 00:05 CEST on Friday, 18 September 2020.

Late-breaking abstracts may be submitted for high quality, new research findings from randomised phase II or phase III trials with implications for clinical practice or understanding of disease processes.

I think CVM abstract is going to be a high quality, new research findings
from randomised phase III trial with implications for clinical practice
like SOC. Any way, I know it is a huge gamble to bet on CVM making the
ESMO, and it is a speculation I can think of CVM PR the results by Aug
18.